Microarray analysis identifies malignant field signatures in biopsy samples at diagnosis predicting the likelihood of lethal disease in patients with localized Gleason 6 and 7 prostate cancer.
The paper identifies a 98-gene signature from microarray analysis of biopsy samples that predicts lethal prostate cancer outcomes in patients with Gleason 6 and 7 tumors.
bioRxiv · Feb 21, 2016 · PreprintGenomics